Continuous infusion 5-fluorouracil (5FU) as a novel treatment for heavily pretreated prostate cancer patients: An update.

被引：4
|
作者：
Manogue, Charlotte
Cotogno, Patrick
Moses, Marcus Marie
Barata, Pedro C.
Layton, Jodi Lyn
Sartor, A. Oliver
Lewis, Brian E.
机构：
[1] Tulane Univ, Ctr Canc, New Orleans, LA 70118 USA
[2] Tulane Canc Ctr, Off Clin Res, New Orleans, LA USA
[3] Tulane Univ, New Orleans, LA 70118 USA
[4] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Med Sch, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
319
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    Chau, I
    Webb, A
    Cunningham, D
    Hill, M
    Waters, JS
    Norman, A
    Massey, A
    BRITISH JOURNAL OF CANCER, 2001, 85 (09) : 1258 - 1264
  • [22] Adjuvant therapy with 5-fluorouracil (5FU) plus levamisole or 5FU plus radiotherapy in resected colorectal cancer.
    Aparicio, J
    Segura, A
    Santaballa, A
    Garcerá, S
    Yuste, A
    López, P
    Tormo, A
    Reynés, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [23] CONTINUOUS 5-FLUOROURACIL (5-FU) INFUSION IN REFRACTORY CARCINOMA OF THE BREAST
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    BEATTY, P
    ANDERSON, T
    JENKINS, D
    FRICK, J
    AUSMAN, R
    CLINICAL RESEARCH, 1986, 34 (04): : A931 - A931
  • [24] Continuous infusion of 5-fluorouracil (5-FU) in neuroendocrine tumours (NET)
    Ducreux, M
    Baudin, E
    Thabut, D
    Rougier, P
    Tigaud, JM
    Elias, D
    Boige, V
    Schlumberger, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S213 - S213
  • [25] INHIBITION OF THE TOXIC ACTIVITY OF 5-FLUOROURACIL (5FU) WITH HYPOTHERMIA
    GAREGNANI, TC
    BARCAT, JA
    MEDICINA-BUENOS AIRES, 1986, 46 (05) : 599 - 600
  • [26] UFT. Biochemical modulation for 5-fluorouracil (5FU)
    Taguchi, T
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 47 - 50
  • [27] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [28] Oxaliplatin (L-OHP) in combination with leucovorin (LV) and 5-fluorouracil (5FU) in pretreated metastatic colorectal cancer (CRC) patients (PTS).
    Di Stefano, A
    Calandri, C
    Benedetti, G
    Poggi, B
    Mazzoni, F
    Marrocolo, F
    Spagnuolo, P
    Rimondini, S
    Crinò, L
    ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [29] Vinorelbine (VNR) plus 5-fluorouracil continuous infusion (5-FU ci) in pretreated advanced breast cancer - Adria Medica Group
    Cobelli, S
    Scanni, A
    Battelli, T
    Pisone, A
    Frontini, L
    Di Lullo, L
    Mattioli, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S17 - S17
  • [30] Schedule dependency of 5-fluorouracil (5FU) chemotherapy in patients with advanced colorectal cancer: A systematic review\ .
    Barrajon, E
    Esquerdo, G
    Lopez, A
    Llorca, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 161S - 161S
12345